Potassium Iodide → 4-(3-Chloro-2-fluoroanilino)-7-methoxy-6-{[(2S)-1-(morpholinoacetyl)pyrrolidin-2-yl]methoxy}quinazoline
Reaction equation
[Cl:1][C:2]1[C:3]([F:32])=[C:4]([CH:29]=[CH:30][CH:31]=1)[NH:5][C:6]1[C:15]2[C:10](=[CH:11][C:12]([O:27][CH3:28])=[C:13]([O:16][CH2:17][C@@H:18]3[CH2:22][CH2:21][CH2:20][N:19]3[C:23](=[O:26])[CH2:24]Cl)[CH:14]=2)[N:9]=[CH:8][N:7]=1.[I-].[K+].[NH:35]1[CH2:40][CH2:39][O:38][CH2:37][CH2:36]1>>[Cl:1][C:2]1[C:3]([F:32])=[C:4]([CH:29]=[CH:30][CH:31]=1)[NH:5][C:6]1[C:15]2[C:10](=[CH:11][C:12]([O:27][CH3:28])=[C:13]([O:16][CH2:17][C@@H:18]3[CH2:22][CH2:21][CH2:20][N:19]3[C:23](=[O:26])[CH2:24][N:35]3[CH2:40][CH2:39][O:38][CH2:37][CH2:36]3)[CH:14]=2)[N:9]=[CH:8][N:7]=1Participants
Reactant 3
Product 1
Procedure
4-(3-chloro-2-fluoroanilino)-7-methoxy-6-{[(2S)-1-(chloroacetyl)pyrrolidin-2-yl]methoxy}quinazoline (0.45 g, 0.94 mmole) was dissolved in morpholine (7.5 ml) and stirred at ambient temperature overnight in the presence of potassium iodide (10 mg). The solvent was evaporated and the residue purified by column chromatography eluting with methylene chloride/methanol (saturated with ammonia) (98/2). The fractions containing the expected product were combined and evaporated under vacuum to give the title product as a foam (0.22 g, 44%); 1H NMR Spectrum: (CDCl3) 1.91-2.01 (m, 1H); 2.06-2.14 (m, 2H); 2.19-2.27 (m, 1H); 2.48-2.53 (m, 2H); 2.62-2.68 (m, 2H); 3.18 (q, 2H); 3.41-3.52 (m, 1H); 3.56-3.72 (m, 5H); 4.01-4.08 (m, 4H); 4.53 (d, 1H); 4.72 (t, 1H); 7.11-7.28 (m, 3H); 7.96 (m, 1H); 8.36 (s, 1H); 8.60 (s, 1H); 8.63 (s, 1H); Mass Spectrum: (M−H)− 528.
Workup
- customThe solvent was evaporated
- customthe residue purified by column chromatography
- washeluting with methylene chloride/methanol (saturated with ammonia) (98/2)
- additionThe fractions containing the expected product
- customevaporated under vacuum
Sources & evidence
- ORD record
- ord-891f6ef095f14def90ff6a40fe7a4295
- Source dataset
- uspto-grants-2013_03
- Patent number
- US08399667B2
Reaction notes
Loading…